Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma

BACKGROUND: The purpose of the study was to evaluate the effect of radiation therapy and chemoradiation with gemcitabine (GEM) after R1 resection in patients with pancreatic adenocarcinoma (PAC). METHODS: We performed a retrospective analysis of 25 patients who were treated with postoperative radiot...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:World J Surg Oncol
Glavni autori: Habermehl, Daniel, Brecht, Ingo C, Bergmann, Frank, Rieken, Stefan, Werner, Jens, Büchler, Markus W, Springfeld, Christoph, Jäger, Dirk, Debus, Jürgen, Combs, Stephanie E
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4404664/
https://ncbi.nlm.nih.gov/pubmed/25889749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-015-0560-3
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items